HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.

Abstract
NK cells hold promise for protecting hosts from cancer and pathogen infection through direct killing and expressing immune-regulatory cytokines. In our study, a genetically modified K562 cell line with surface expression of 4-1BBL and MICA was constructed to expand functional NK cells in vitro for further adoptive immunotherapy against cancer. After a long-term up to 21 day co-culture with newly isolated peripheral blood mononuclear cells (PBMCs) in the presence of soluble IL-21 (sIL-21), notable increase in proportion of expanded NK cells was observed, especially the CD56(bright)CD16(+) subset. Apparent up-regulation of activating receptors CD38, CD69 and NKG2D was detected on expanded NK cells, so did inhibitory receptor CD94; the cytotoxicity of expanded NK cells against target tumor cells exceeded that of NK cells within fresh PBMCs. The intracellular staining showed expanded NK cells produced immune-regulatory IFN-γ. Taken together, we expanded NK cells with significant up-regulation of activating NKG2D and moderate enhancement of cytotoxicity, with IFN-γ producing ability and a more heterogeneous population of NK cells. These findings provide a novel perspective on expanding NK cells in vitro for further biology study and adoptive immunotherapy of NK cells against cancer.
AuthorsBo Jiang, Xuan Wu, Xi-Ning Li, Xi Yang, Yulai Zhou, Haowei Yan, An-Hui Wei, Weiqun Yan
JournalCellular immunology (Cell Immunol) Vol. 290 Issue 1 Pg. 10-20 (Jul 2014) ISSN: 1090-2163 [Electronic] Netherlands
PMID24859012 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • 4-1BB Ligand
  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • CD56 Antigen
  • CD69 antigen
  • FCGR3B protein, human
  • GPI-Linked Proteins
  • Histocompatibility Antigens Class I
  • Interleukins
  • KLRD1 protein, human
  • KLRK1 protein, human
  • Lectins, C-Type
  • MHC class I-related chain A
  • Membrane Glycoproteins
  • NCAM1 protein, human
  • NK Cell Lectin-Like Receptor Subfamily D
  • NK Cell Lectin-Like Receptor Subfamily K
  • Receptors, IgG
  • Interferon-gamma
  • CD38 protein, human
  • ADP-ribosyl Cyclase 1
  • interleukin-21
Topics
  • 4-1BB Ligand (biosynthesis, genetics)
  • ADP-ribosyl Cyclase 1 (biosynthesis)
  • Antigens, CD (biosynthesis)
  • Antigens, Differentiation, T-Lymphocyte (biosynthesis)
  • CD56 Antigen (biosynthesis)
  • Cell Line, Tumor
  • Coculture Techniques
  • GPI-Linked Proteins (biosynthesis)
  • HeLa Cells
  • Hep G2 Cells
  • Histocompatibility Antigens Class I (biosynthesis, genetics)
  • Humans
  • Immunotherapy, Adoptive
  • Interferon-gamma (biosynthesis, immunology)
  • Interleukins (biosynthesis, genetics, pharmacology)
  • Killer Cells, Natural (immunology)
  • Lectins, C-Type (biosynthesis)
  • Lymphocyte Activation (immunology)
  • Membrane Glycoproteins (biosynthesis)
  • NK Cell Lectin-Like Receptor Subfamily D (biosynthesis)
  • NK Cell Lectin-Like Receptor Subfamily K (biosynthesis)
  • Neoplasms (immunology, therapy)
  • Receptors, IgG (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: